CURRICULUM VITAE

III. BOARD CERTIFICATION

American Board of Urology, 1975

IV. LICENSES

Oklahoma Missouri Texas California

V. PROFESSIONAL EXPERIENCE

Academic and Teaching

1989‑10/1/96 Professor of Urology (tenured)

University of Oklahoma

College of Medicine

1981‑1988 Associate Professor of Urology

University of Oklahoma

College of Medicine

1980‑present Coordinator, Clinical Clerkships

Department of Urology

University of Oklahoma College of Medicine

1975‑1980 Assistant Professor of Urology

University of Oklahoma College of Medicine

1972‑1975 Assistant in Urology

University of Oklahoma

College of Medicine (on leave of absence)

1974‑1975 Clinical Assistant Professor of Surgery

University of Hawaii School of Medicine

Administrative

7/93-7/94 Chief: Urology Services

The University Hospital, Oklahoma City

11/91-10/96 Chief, Urology Section

Veterans Administration Medical Center

Oklahoma City, Oklahoma

9/91‑11/91 Acting Chairman, Department of Urology

University of Oklahoma

College of Medicine

1977‑1991 Chief, Urology Section

Veterans Administration Medical Center

Oklahoma City, Oklahoma

1983‑1996 Director, Andrology Laboratory

Oklahoma Medical Center

Oklahoma City, Oklahoma

1984‑1996 Director, Urodynamic Laboratories

Oklahoma Medical Center

Oklahoma City, Oklahoma

1975‑1977 Operational Chief, Urology Section

Veterans Administration Medical Center

Oklahoma City, Oklahoma

1975‑1980 Chief, Renal Transplant Program

U. of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma

1972‑1975 Chief, Division of Urology

Kaiser Foundation Hospitals of Hawaii

Clinical

10/1/96 Private Practice specializing in Urology

Edmond, Oklahoma

1996 - Attending, Columbia Edmond Regional Medical Center

1996 - Attending, Logan County Hospital and Medical Center

1996 - Attending, Horizon Specialty Hospital

1975‑1996 Attending, University of Oklahoma Teaching Hospitals

Oklahoma City, Oklahoma

1977‑1996 Attending, Veterans Administration Medical Center

Oklahoma City, Oklahoma

1999 - Courtesy Staff: Mission Hill Hospital

Shawnee, Oklahoma

2000 - Courtesy Staff: Shawnee Regional Hospital

Shawnee, Oklahoma

1977‑1996 Consultant, Veterans Administration Medical Center,

Muskogee, Oklahoma

1975‑1996 Attending, Children's Hospital of Oklahoma

Oklahoma City, Oklahoma

1977‑1994 Attending, O'Donoghue Rehabilitation Institute Oklahoma City, Oklahoma

1980‑present Courtesy Staff, HCA Presbyterian Hospital

Oklahoma City, Oklahoma

1981‑1996 Consultant, St. Joseph Medical Center

Ponca City, Oklahoma

1998 - Courtesy Staff: Mercy & Deaconess Hospitals

Oklahoma City, Oklahoma

VI. COMMITTEES AND SPECIAL ASSIGNMENTS

National

1994-1999 Member, Editorial Board, Journal of Urology

1993-present Member, Safety Monitoring Board

National Institute of Aging

National Institutes of Health

1990‑present Member, Panel of Experts, American Medical Association, Diagnostic and Therapeutic Technology Assessment Program

1990‑1991, 1993 Member, Program Committee of the AUA

1994, 1995, 1996

1988‑1991 Delegate, Research Committee from the South Central Section

to the AUA

1992‑1994 Member, International Relations Committee, AUA

1988‑1991 Member, Research Committee, AUA

1993-1994 Member, Audiovisual Committee, AUA

1988‑1999 Member, Terminology Committee, AUA

1995-1996 Vice Chairman, Public Media Committee, AUA

1988‑1990 Special Consultant, Agent Orange

Commission, State of New Jersey

1986‑1990 Council of Medical Specialty Societies, Alternate Representative from the American Urological Association

1984‑1990 Member, Sessions Management Committee

American Fertility Society

1986‑1988 Alternate Delegate, Research Committee, AUA

1985‑1988 Member, Registration Committee, American Fertility Society

Regional

1988‑1990 Chairman, Residents Program Committee

South Central Section, AUA

1979‑1987 Member, Residents Program Committee,

l991‑1993 South Central Section, AUA

1987‑1989 Board Member, Veterans Administration

Medical District 19

Initiated Peer Review Organization

1983‑1986 Elected Representative, State of Oklahoma

to the South Central Section, AUA

1980‑1982 Member, Allied Health Committee

South Central Section, AUA

1990‑1992 Member, Future Meetings Committee, South Central Section, AUA

State

1980‑1981 President, Oklahoma State Urological Association

1977‑1979 Secretary‑Treasurer, Oklahoma State Urological Association

1979‑1980 President, National Kidney Foundation of Oklahoma

1979‑1980 Chairman, Medical Advisory Board

National Kidney Foundation of Oklahoma

1977‑1979 Vice‑Chairman, Medical Advisory Board,

National Kidney Foundation of Oklahoma

1974‑1975 Chairman, Professional Information

Committee American Cancer Society,

Honolulu, Hawaii

Local / University

1988‑1989 Vice Chairman, Academic Program Council

University of Oklahoma Health Sciences Center

1986‑1988 Member, Academic Program Council

University of Oklahoma Health Sciences Center

1986‑1989 Member, Faculty Senate Committee on Faculty Affairs, University of Oklahoma Health Sciences Center

1. College of Medicine

1996-1997 Alternate Representative, OUHSC Faculty Senate

1982‑1996 Clinical Course Coordinator, College of Medicine

1977‑1981 Counselor, Sophomore Class, College of Medicine

1977‑1978 Member, Fourth Year Promotion Committee College of Medicine

1975‑1977 Member, Academic Council, College of Medicine

2. Department of Urology

1982‑1996 Member, Executive Committee

1981‑1996 Member, Promotion & Tenure Committee

1980‑1996 Faculty Coordinator, Medical student assignments and lectureships

1975‑1996 Faculty Coordinator. Library and Audio‑visual programs

3. Veterans Administration Medical Center

1995-1996 Member, Research and Development Committee

1986‑1989 Member, Pharmacy and Therapeutic Committee

1983‑1989 Chairman, Quality Assurance Committee

1983‑1996 Chairman, Medical Records Committee

1983‑1989 Member, Clinical Executive Board

1982‑1983 Member, Utilization Review Subcommittee

1977‑1983 Chairman, Patient Care Review Committee

1975‑1977 Member, Patient Care Review Committee

1975‑1980 Member, End‑Stage Renal Disease Subcommittee

4. Oklahoma Medical Center (University Hospital)

1996 Member, Laser Committee, TUH

1982‑1994 Member, Infection Control Committee

1979‑1980 Chairman, Medical Records Committee

1979‑1980 Member, Patient Care Committee

1978‑1983 Member, Institutional Review Committee For Intraocular Lenses,

1977‑1980 Member, Utilization and Audit Committee

1975‑1980 Member, Renal Dialysis/Transplant Committee

5. Oklahoma County Medical Society

2000 President, Oklahoma City Clinical Society

1999 President, Oklahoma County Medical Society

1998 President Elect, Oklahoma County Medical Society

1999 President Elect, Oklahoma City Clinical Society

1997 Vice President, Oklahoma City Clinical Society

1996 Member, Board of Directors, Oklahoma County Medical Society

1996 Secretary, Oklahoma City Clinical Society

1983,1987,1988, Alternate Delegate and Delegate, Oklahoma County

1992-present Medical Society to Oklahoma State Medical Association

1991‑1993 Member, Medical Forum Committee

1989-present Member and Vice-Chairman, Editorial Board, Oklahoma County Medical Society

1995-present Assistant Editor Oklahoma Medical Society Bulletin

VII. MEMBERSHIPS AND RECOGNITIONS

Awards and Honors

1982 Sigma Xi Honorary Research Society

1977 1st prize art exhibitor "Watercolor Category" at the 56th Annual Mtg., SouthCentral Section, American Urological Association, Shangri La, OK

1976 Honorable mention as exhibitor "Instruction in Catheter Care for Hospital Personnel and Patients" AMA 125th Convention, Dallas, Texas

1975 Secretary to the Medical Staff, Kaiser Permanente Medical Group, Honolulu, Hawaii

1971 Best Paper in Urology,University of

Oklahoma Housestaff Association

1970 2nd prize ‑ Residents' Program, South

Central Section, AUA, St. Louis, Missouri

Professional and Scientific Memberships

1975‑present Oklahoma State Medical Association

1975‑present Oklahoma County Medical Association

1975‑present South Central Section, American Urological Association

1975‑present Oklahoma State Urologic Society

1976‑present American Urological Association

1976‑present Oklahoma City Clinical Society

1976‑2000 Society of University Urologists

1976‑1988 National Kidney Foundation

1977‑present American College of Surgeons

1977‑2000 American Fertility Society

1978‑1989 International College of Surgeons

1981‑1996 Association of Military Surgeons

1982‑present American Andrology Society

1983‑present American Medical Association

1985‑present New York Academy of Sciences

1990‑1995 Society for Basic Urologic Research

1991‑present Society International d'Urologie

1993-present Society for the Study of Reproduction

1993-present Society for the Study of Impotence

1995-1996 Society for Urology and Engineering

Listings

1980‑1988 Who's Who in America South & Southwest Sections

1984 Who's Who in the World, 7th Ed.

1984 Men of Achievement, 8th Ed.

1980 Personalities of the South, 11th Ed.

Ad Hoc Referee for Peer Journals

Journal of the American Medical Association (JAMA)

Urology

Journal of Andrology

Infections in Urology

VIII.RESEARCH INTERESTS

PRINCIPAL INVESTIGATOR

1. Rapid Antibiotic Suspectibility Method Utilizing Hemoglobin Reduction Technique. (N.I.H. Grant), 1970‑1971. (Advisor Dr. Warren Jackson, Professor of Microbiology)

2. Alkalinization of Urine in the Treatment of Urinary Candidiasis, 1970 ‑ 1971. (Fellowship)

3. Chromosomal Analysis of Bladder Cancer (Small Grant from University of Oklahoma College of Medicine), 1978 ‑1979.

4. The Use of Ultrasonography in the Diagnosis of Prostatic Neoplasia. In collaboration with Dr. Ross Brown, formerly Chief of Ultrasound of Oklahoma University Health Sciences Center, presently at University of Manitoba, Canada, 1978-1979.

5. Clinical Evaluation of LY127935 (investigational antibiotic) in treatment of urinary tract infection (Grant from Lilly Research Laboratories), 1979 ‑1981.

6. Utilization of Leukocyte Esterase in Rapid Detection of Pyuria. (Partial support from Boehringer Mannheim Diagnostics)

7. Tumor Markers in Bladder Tumors (cytogenetic markers and cell surface isoantigens) ‑ Joint Effort with National Cancer Institute, 1980 ‑ 1981.

8. Open Study of Mezlin in Treatment of Urinary Tract Infection, Miles, 1982 ‑1983. (Grant from Miles, Inc.)

9. Capacitation of spermatozoa with Glycosaminoglycan, 1985‑1988. (Departmental support in conjunction with Dr. Robert Hurst)

10. Treatment of Interstitial Cystitis with Investigational Drug (Elmiron) Subcontract of N.I.H. Grant through University of California at San Diego, 1987 ‑ 1991.

11. Clinical trial (Phase II) on the use of (MK‑906) a 5‑alpha reductase inhibitor on the growth of the prostate. Sponsored by Merck and Company, 1988‑1996.

12. Prospective, controlled, double blind, randomized, multicenter clinical trial of Ciprofloxacin versus Idamyl Carbenicillin versus Trimethoprim/sulfamethoxazole in the treatment of chronic bacterial prostatitis. Sponsored by Miles, Inc., 1989‑1990

13. Clinical Trial of Micturin vs Placebo in Urge Incontinence in Prostatectomized Male: Sponsored by a grant from Forest Laboratories, New York, 1990‑1991

14. Clinical Trial of Micturin vs. Placebo in the Treatment of Urge Incontinence in Women. Sponsored by Forest Lab., New York, 1991.

15. A Double‑Blind, Randomized, Placebo‑Controlled Dose Ranging Study of Atamestane to Evaluate the Efficacy, Safety and Endocrinological Effects in Symptomatic Patients with Benign Prostate Hyperplasia. Sponsored by Berlex Lab., Inc., Wayne, N.J. 1991‑1993.

16. A Double‑Blind, Randomized, Placebo‑Controlled (Phase III), Multicenter Study to Investigate the Long‑Term Effects of Finasteride (MK‑906) in Patients with Benign Prostatic Hyperplasia (Merck & Co.). 1989‑1996

17. Double Blind, Placebo Controlled Study to Investigate the Safety and Efficacy of MK‑434 in Patients with B.P.H. Merck & Co. 1992 ‑ 1993

18. A Double Blind, Randomized, Placebo-Controlled Multicenter Study to Investigate the Long‑Term Effects of Finasteride (MK‑906) in Patients with Benign Prostatic Hyperplasia. 1992-1996

19. Long‑Term Safety Study with Alprostadil (PGEl) in patients with Erectile Dysfunction. G.H. Besselaar/Upjohn. 1992-1995

20. Establishment of South Central Interstitial Cystitis Clinical Center (NIDDK), N.I.H. grant. 1992 ‑ 8/1996.

21. RFA-92-18 Treatment of Benign Prostatic Hyperplasia - Pilot Study. NIDDK, National Institutes of Health (Total Cost: $423,513). Grant Submitted. (Not funded)

22. A study to examine the effects of Finasteride on serum prostate specific antigen in men with BPH. Merck Research Lab grant. 1993-1994.

23. Phase II Trial of topical Minoxidil in the treatment of erectile dysfunction in men with and without diabetes mellitus. Upjohn Co. grant. 1993.

24. Evaluation of the Safety and Efficacy of Alprostadil Administered by MUSE. Grant from VIVUS, Inc. 1994-1996

25. Medical Therapy In Benign Prostatic Hyperplasia. NIDDK, National Institutes of Health.1,614,823). Grant Submitted (Not funded) 1995

26. A double-blind, randomized, placebo-controlled, multicenter study to evaluate the safety of low dose Finasteride in Male Volunteers. (Merck & Co.), 1995 - 1996

27. Dose-response Efficacy and Safety of an Aqueous NTG Topical Craem in the Treatment of Male Impotence (IMI Grant) 1995-1996

CO‑INVESTIGATOR

1. Jack Metcoff, M.D. ‑ Professor of Pediatrics, Biochemistry and Molecular Biology ‑Preservation and Regeneration of Isolated Kidneys (N.I.H. Grant), 1975 ‑1976.

2. Anil Mandal, M.D. ‑ Acute Renal Failure Produced by Epinephrine and Methemoglobin infusion (NIH Grant), 1975‑1976.

3. W.L. Parry, M.D. ‑ A Sixteen Week Double Blind Placebo Controlled Dose Response Study Using Doxazosin Tablets for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension. Pfizer, Inc.1990-1995

4. W. L. Parry, M.D. ‑ Clinical Trial Comparing The Safety And Efficacy of Alpha Blockade And Androgen Suppression For The Treatment Of Benign Prostatic Study #359. 1992-1995

5. R.E.Hurst, Ph.D, ‑ Proteoglycans an~ Glycoproteins of Bladder Defenses. NIH, DK93‑19 Interstitial Cystitis And Other Bladder Disorders of Women. (Submitted 4/93)

6. R. E. Hurst, Ph.D. ‑ Altered Gene Expression in Interstitial Cystitis, NIDDK. Innovative Approaches to Interstitial Cystitis. 1993-1996.

IX. SCIENTIFIC PUBLICATIONS

1. Roy, J.B., Abdulian, M. And Walton, K.N.: Chylous Ascites, J. Urology, 103:343, 1970.

2. Roy, J.B. And Walton, K.N.: Secondary Tumors of the Kidney, J. Urology, 103:411, 1970.

3. Roy, J.B., Jackson, J.L.W., Johnson, J., And Geyer, J.R.: Evaluation of Sellers‑Schmidt‑Ball Rapid Antibiotic Susceptibility Test, J. Urology, 105:615, 1972.

4. Roy, J.B.: Intercourse Cystitis, Hawaii Medical Journal, 33:418, 1974.

5 Roy, J.B.: Acupuncture Needle in Bladder: Urology 4:484, 1974.

6. Roy. J.B. and Stevens, R.K.: Urinary Candidiasis, Urology, 1974.

7. Roy, J.B. and Stevens, R.K.: Polycystic Horseshoe Kidney Urology, 6:222, 1975.

8. Roy, J.B., Cruz, D.D. and Bhagavan, N.V.: Extraosseous Myelomatosis, Urology 8:280, 1976.

9. Roy, J.B. (Member of Panel): Play It Safe with Urethral Catheter, Patient Care X:106, 1976.

10. Sethney, H.T. and Roy, J.B.: Impotence ‑Management with Penile Prosthesis, Oklahoma State Medical Journal 69:428, 1976.

11. Roy, J.B., Hamblin, D.W. and Brown, C.H.: Periarteritis Nodosa of Epididymis, Urology X:62, 1977.

12. Roy, J.B., Tacker, J.R., Hamblin, D.W. and Wilkerson, R.: Office Bacteriology, Welcome Trends in Urology 1:3, 1979.

13. Roy, J.B.: Obtaining Clean Catch Urine Specimen in an Adult Female, Patient Care 12:177, 1979.

14. Roy, J.B.: Obtaining Clean Catch Urine Specimen (male child), Patient Care 13:148, 1979.

15. Roy, J.B., Baumann, W.E., Lewis, T.M., et al.: Adenocarcinoma of Rete Testis, Urology XIV:270, 1979.

16. Roy, J.B.: Obtaining Clean Catch Urine Specimen (adult male), Patient Care 13:613, 1979.

17. Mosca, P. And Roy, J.B.: Outpatient Needle Biopsy of Prostate, Oklahoma State Medical Journal 73:3, 1980.

18. Roy, J.B.: The Role of the Physician in Sex Counseling, Oklahoma State Medical Journal 73:101, 1980.

19. Leonard, J.C., Roy, J.B., et al.: Technetium Sulphur Colloid Scanning in Diagnosis of Renal Transplant Rejection, J. Urology 123:815, 1980.

20. Roy, J.B.: Obtaining Clean Catch Urine Specimen (female child), Patient Care 14:120, 1980.

21. Roy, J.B., Dagg, K., Bottomley, R.H.: Chromosomal Analysis of Transitional Cell Carcinoma, Surgical Forum, XXXII:616, 1981.

22. Javadpour, N., Roy, J.B., et al.: Combined Cell Surface Antigens and Chromosomal Studies in Bladder Cancer, Urology XIX:29, 1982.

23. Roy, J.B.: Impotence: A Surgically Manageable Disease, Oklahoma State Medical Journal 76 (2~:41‑44, 1983.

24. Herlihy, R.E., Wilkerson, R., Roy, J.B.: New and Rapid Method for Detection of Pyuria by Leukocyte Esterase Reaction, Urology, XXIII(2):148‑149, 1984.

25. Roy, J.B., Wilkerson, R.G.: The Fallibility of the Griess (Nitrite) Test, Urology, XXIII(3):270‑271, 1984.

26. Willis, R.J., Geyer, J.R., Roy, J.B.: Renal Adenocarcinoma: Results of Radical Nephrectomy in 81 Patients. Military Med. 149:251‑253, 1984.

27. Roy, J.B., Geyer, J.R., Mohr, J.A.: Urinary Tract Candidiasis: An Update. Urology XXIII(6):533‑537, 1984.

28. Roy, J.B., Bernitsky, L.G., Hill, M.R., et al.: The Effect of Experimentally Induced Pyelonephritis on the Testicular Histology in Rats. Fertil. & Steril. 41:(Suppl)285, 1984.

29. Roy, J.B., Bernitsky, L.G., DeBault, L., et al.: Flow Cytometric Evaluation of Altered Spermatogenesis Induced by Systemic Infection. Surgical Forum XXXV:632‑634, 1984.

30. Roy, J.B., Dagg, K., and Bottomley, R.H.: Cytogenetic Aberrations in Bladder Carcinoma. Military Med. 149:622- 623, 1984.

31. Roy, J.B. And Parry, W.L.: Cytogenetic Effects of TCDD (DIOXIN): A Perspective of FERTILITY. J. Androl.6(Suppl.):59, 1985.

32. Hurst, R.E., Roy,. J.B., Bynum, R.L., and Parry, W.L.: Abnormal Glycosaminoglycan Excretion in Patients with Chronic Interstitial Cystitis. J. Urol. 33(4):144A, 1985.

33. Roy, J.B. and Robinson, P.D.: An alternative to Urine Microscopy. VA Practit 3:68, 1986.

34. Roy, J.B. and Wilkerson, R.: Mezlocillin: A broad spectrum penicillin in the treatment of urinary tract infection. Milit. Med. 151:315, 1986.

35. Roy, J.B. and Robinson, P.D.: Biochemical Urine Screening: rationale and advantages. J. Okla. State Med. Assoc. 79:234, 1986.

36. Roy, J.B., Said, S.I., Paul, S. and Parry, W.L.: Decreased VIP Immunoreactivity in Cavernous Tissue from Men with Organic Erectile Failure. Surg. Forum XXXVII:638, 1986.

37. Bernitsky, L.G. and Roy, J.B.: Male Infertility and Genitourinary Infections. Infertility 9(2):129‑144, 1986.

38. Hurst, R.E., Rhodes, S., Adamson, P.B., Parson, L. and Roy, J.B.: Functional and Structural Characteristics of the Glycosaminoglycans of the Bladder Lumenal Surface. J. Urol. 138:433‑437, 1987.

39. Roy, J.B.: Evaluating the Patient with Hematuria. Hosp. Med. 97‑112, Oct. 1987.

40. Hurst, R.E., Bynum, R.L., Enfield,S.E. and Roy, J.B.: The Identification of a Heparin‑Binding Protein on the Surface of Bovine Sperm. Biochem. Biophy. Res. Comm. 153(1):289, 1988.

41. Steinberg, J.B., Remis, R.E. and Roy, J.B.: Urethral Diverticulum in Women; An Update with a Case Presentation. Milit. Med., 153:424‑426, 1988.

42. Roy, J.B., Petrone, R.L. and Said, S.J.: Clinical Trial of Intracavernous Vasoactive Intestinal Peptide to Induce Penile Erection. J. Urol. 143:302‑304, 1990.

43. Roy, J. B., Petrone, R. L. and Ibrahim, T.A.: A Clinical Trial of the Intracorporal Injection of Papaverine/Phentolamine vs. PGE, vs Topical Nitroglycerin Ointment in the Treatment of Erectile Dysfunction. International J. Impotence. Res. 2 (suppl.2): 305‑306, 1990

44. Roy, J. B.: The Dawn of a New Era on Benign Prostatic Hyperplasia. Bull. Okla. County Med. Soc. 63:(5)15‑16, 1990 .

45. Roy, J. B. : Cancer of the Prostate ‑ An Overview. J. Okla State Med. Assoc. 83:591‑595, 1990

46. Roy, J. B.: Urinary Incontinence: A Leaky Problem. Bull. Okla. County Med. Soc. 10:(6) 19‑21, 1991.

47. Roy, J. B.: Impotence. Geriatric Med. Today. 10:(7~ 35‑43, 1991.

48. Stoner, E. and Finasteride Research Group ‑ Roy, J.B., member of the Group: Clinical Effects of 5‑alpha‑reductase inhibitor Finasteride on Benign Prostatic Hyperplasia. J. Urol 147:1298, 1992.

49. Bodansky, M., Sharaf, H., Roy, J.B., and Said, S.I.: Contractile Activity of Vasotocin, Oxytocin, and Vasopressin in Mammalian Prostate. Europ. J. Pharmacol. 216:311‑313, 1992.

50. Roy, J.B.: Hematuria. Hosp. Med. 28(10):101‑114, 1992.

51. Roy, J.B.: Prostate Cancer: Cancer of the Prostate. Bull Oklahoma Co. Medical Society 65 (6) 9-11, 1992.

52. Roy, J.B.: Prostate Diseases: Progress In Prostate Diseases. Bull. Oklahoma Co. Medical Society. 65(10) 13-16, 1992

53. Gormley, G. and Finasteride Research Group ‑ Roy, J.B., member of the Group: The Effects of Finasteride in Men with Benign Prostatic Hyperplasia. N.E.J.Med. 327(17):1185‑1191,1992.

54. Hurst, R.E., Parson, C.L., Roy, J.B., and Young J. L.:Urinary Glycosaminoglycan Excretion as Laboratory Marker in Diagnosis of Interstitial Cystitis. J. Urol 149:31‑35, 1993.

55. Roy, J.B.: Interstitial Cystitis. Bull. Oklahoma County Medical Society 66(4) 11, 1993.

56. Stoner, E. and Finasteride Study Group, J.B. Roy, member of Group. Three Year Safety and Efficacy Data On The Use of Finasteride in the Treatment of Benign prostatic Hyperplasia. Urology 43:284, 1994.

57. Stoner, E. and the Finasteride Study Group, J.B. Roy, member of Group: Clinical Experience of the Detection of Prostate Cancer in Patients with Benign Prostatic Hyperplasia Treated with Finasteride. J. Urol. 151:1296-1300, 1994.

58. Mobley, D. F. and Doxazosin Study Group, J.B. Roy, member of Group: Doxazosin Therapy for benign prostatic hyperplasia: A multicenter Study. J. Urol 151(5): 267A, 1994.

59. Roy, J.B., Petrone, R.L., Agha, A. H.: Comparative pharmacokinetics and hemodynamics of the topical application to the penis of nitroglycerin ointment vs. an aqueous nitroglycerin gel in health male volunteers. Intl. J Impotence Res. 6(Suppl.1): 90. 1994

60. Gillenwater, J.Y., Cann, R. L., Chrysant, S., Roy J, et. al.: Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: A double-blind study. J of Urol 154:110-115, 1995.

61. Evon Moore, M.S., Bracken, B., Bremner, W., Geller, J, Imperator-McGinley, J., McConnell, J., Roy, J, et. al.: PROSCAR: Five Year Experience. Euro. Urol. 28:304, 1995.

62. Agha, A., Roy, J.B., Culkin, D.J. and Lyon, K.: The Impact of 5-Apha-Reductase Inhibitors on the Number of Prostatectomies for B.P.H., Adv. Therapy 12(6): 361,1995.

63. Agha, A.H., Schecter, E., Roy, J.B., Culkin, D.J.: Prostate Specific Antigen Is Metabolized In The Liver. J.Urol. 155:1332-1335, 1996.

64. Roy, J.B.: Infertility: A Silent Disease. Bull. Oklahoma County Medical Soc. 68(1) 11- 12, 1995.

65. Roy, J.B.: Penile Lengthing: A New Fad Or A Truly Scientific Procedure. Bull. Oklahoma County Medical Soc. 68(2) 11, 1995.

66. Roy, J.B.: A Male Pill (Sperm Stopper). Bull. Oklahoma County Medical Society. 68(4) 17-18, 1995.

67. Linet O.I., Orgrinc, F.G. for the Study Group (Dr. Roy, member of the Group) Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction. N Engl J Med 334-873-7. April 4, 1996.

68. Osterling, J., Shown, T., and Finasteride Study Group (Dr Roy is member of this group) et al.: The Biologic Variability of PSA and Its Usefulness as a Marker for Prostate Cancer; Effects of Finasteride. (submitted to Journal of Urology)

69. Roy, J.B., and Petrone, R.L.: Dose Response, Efficacy and Safety of Topical Application to the Penis of Aqueous Nitroglycerin Cream in Men with Erectile Dysfunction. Intl. J. Impotence Res. 8(3):115 1996

70. Hurst, R.E., Roy, J.B., et al: A Deficit of Chondroitin Sulphate Proteoglycans on the

Bladder Uroepithelium in Interstitial Cystitis. Urology 48(5): 817-821, 1996.

71. Roy, J.B.: Andropause, The Analog to Menopause. Bull. Oklahoma County Medical

Society 69(10):9,1996.

72. Padma-Nathan, H. and the MUSE Study Group, Roy, J.B., (member of the group),

Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil, N. Engl. J.

Med. 336(1):1-7, 1997.

73. Roy, J.B.: DHEA: A Fountain of Youth or Faux Remedy. Bull. Oklahoma County Medical

Society, 70(1): 11-12, 1997.

74. Roy, J.B.: AIDS - Brief Milestones. Bull. Oklahoma County Medical Society 70(2):7,1997.

75. Lepor, H. and Multi-center Study Group Roy, J.B., (member of the group), Doxazosin For

Benign Prostatic Hyperplasia: Long-term efficacy and Safety in Hypertensive and

Normotensive Patients. J. Urol. 157:525, 1997.

76. Osterling, J.E., Roy, J.B., et al: Biologic Variability of Prostate Specific Antigen and Its

Usefulness as a Marker for Prostate Cancer: Effects of Finasteride. Urol. 50: 13-18, 1997.

77. Roy, J.B.: Alternative Therapy (Complementary Therapy). Bull. Oklahoma County

Medical Society, 70 (8): 9-10, 1997.

78. Roy, J.B.: Androgenetic Alopecia (Male-Pattern Baldness). Bull. Oklahoma County

Medical Society, 70 (9): 11-13, 1997.

79. Roy, J.B.: Advances in The Management of Impotence. J. Oklahoma State Medical

Association 91: 14-16, 1998.

80. Roy, J.B.: Adoption- A Brief Review. Bulletin Oklahoma County Medical Society.

71 (4): 9, 1998.

81. McConnell, J.D. and the Finasteride Study Group - J.B. Roy (member of the Study

Group): The Effects of Finasteride on the Risk of Acute Urinary Retention and the

need for Surgical Treatment Among Men With Benign Prostatic Hyperplasia. N.E.J.

338 (9): 557-563, 1998.

82. Andriole, G.L., Guess, H.A., and the PLESS Study Group: Treatment with Finasteride

Preserves Usefulness of Prostate Specific Antigen in the Detection of Prostate Cancer:

Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trials.

Urology 52: 195-202, 1998.

83. Roehrborn, C.G., McConnell, J, et al for the PLESS Study Group (Dr. Roy: Member

of Study Group). Urology 53: 473-480, 1999.

84. Hudson, P.B. Boake,R. Roy, J.B. and the North American Finasteride Study Group:

Efficacy of Finasteride is Maintained in Patients with B.P.H. Treated for 5 years.

Urology 53: 690-695, 1999.

85. Ximig, J.Y., Lecksell,K. Epstein, J.I. for the PLESS Study Group (Dr Roy: member

of the Group): Urology 53: 696-700, 1999.

86. Overstreet, J.W., Fuh, V.L., Roy, J.B. etal: Chronic Treatment with Finasteride Daily

Does Not Affect Spetmatogenesis Or Semen Production In Young Men. J.Urol.,

162: 1295-1300, 1999.

87. Roehrborn, CG, Boyle, P et al for PLESS Study Group (J.B. Roy member of

Group): Serum Prostate-Specific Antigen and Prostate Volume Predict Long-

Term Changes in Symptoms and Flow Rate: Results of a 4-year, Randomized Trial

Comparing Finasteride Versus Placebo. Urol. 54 (4):662-669, 1999.

88. Bruskewitz, R., Girman, C. et al for the PLESS GROUP (J.B. Roy member of

Group): Effect of Finasteride on Bother and Other Health-Related Quality of Life

Aspects Associated with B.P.H. Urol 54 (4): 670-678, 1999.

89. Roehrborn, CG, McConnell, J, Roy, JB et al for PLESS GROUP: Serum Prostatic Specific

Antigen in strong Predictor of Future Prostate Growth in Men with B.P.H. J Urol 163: 13-20, 2000

X. SCIENTIFIC EXHIBITS PRESENTED

1. Instructions in Catheter Care for Hospital Personnel and Patients. Johnny B. Roy,, M.D., James R. Geyer, M.D., Margaret Tannehill, R.N. and Norma Seymour, R.N. Presented Scientific Exhibit of the American Medical Association, Dallas, Texas, June 28‑30, 1976.

2. Renal Lymphatic. Johnny B. Roy,, M.D., William L. Parry, M.D., Richard Bell, Ph.D. and Jack Keyl, Ph.D. Presented at the Scientific Exhibit of the American Medical Association, Dallas, Texas, June 28‑30, 1976.

3. Instruction in Catheter Care for Hospital Personnel and Patients. Johnny B. Roy,, M.D., James R. Geyer, M.D., Margaret Tannehill, R.N. and Norma Seymour, R.N. Presented at the annual Meeting of the South Central Section of the American Urological Association, San Antonio, Texas, September 12‑16, 1976.

4. Office Bacteriology. Ron Tacker, M.D., Ron Wilkerson, B.S. and Johnny B. Roy,, M.D. Presented at the 56th Annual Meeting of the South Central Section of the American Urological Association, Shangri‑La, Oklahoma, October 1‑5, 1977.

5. Sound Approach to Renal Masses. Johnny B. Roy,, M.D. and Ross Brown, M.D. Presented at the 58th Annual Meeting of the South Central Section of the American Urological Association, Albuquerque, New Mexico, October 7‑10, 1979.

6. CAT Scan of the Kidney. James R. Geyer, M.D., Sidney Traub, M.D. and Johnny B. Roy,, M.D. Presented at the 58th Annual Meeting of the South Central Section of the American Urological Association, Albuquerque, New Mexico, October 7-10, 1979.

7. Tumor Markers in Bladder Carcinoma. Johnny B. Roy,, M.D. Presented at the Annual Meeting of the South Central Section of the American Urological Association, Dallas, Texas, September 10‑13, 1981.

XI. PAPERS PRESENTED/ABSTRACTS

1. Southern Medical Association Meeting, Atlanta, Georgia, "Chylous Ascites", 1969.

2. Annual Meeting of Society of University Urology Residents, New Haven, Connecticut, "Experiences with Renal Tuberculosis", May 1970.

3. University of Oklahoma House Staff Annual Meetings Oklahoma City, Oklahoma, "Rapid Antibiotic Sensitivity Method", October 1971.

4. South Central Section of the American Urological Association, St. Louis, Missouri, "Evaluation of Rapid Antibiotic Sensitivity Method", October 1971.

5. South Central Section of the American Urological Association, San Juan, Puerto Rico, "Extraosseous Myelomatosis", September 30, 1975.

6. 56th Annual Meeting of the South Central Section of the American Urological Association, "Penile Prosthesis", October 1977.

7. 57th Annual Meeting of the South Central Section of the American Urological Association, "Office Bacteriology". October 1978.

8. 57th Annual Meeting of the South Central Section of the American Urological Association, "The Role of the Urologist in Sex Counseling", October 1978.

9. 58th Annual Meeting of the South Central Section of the American Urological Association, Albuquerque, New Mexico, "Experiences with Penile Prostheses", October 9, 1979.

10. 58th Annual Meeting of the South Central Section of the American Urological Association, Albuquerque, New Mexico, "Sexual Dysfunction", October 9, 1979.

11. Annual Meeting of the Oklahoma State Urological Association, "Chromosomal Study of Bladder Tumors", Oklahoma City,Oklahoma, May 5, 1980.

12. 59th Annual Meeting of the South Central Section of the American Urological Association, "Chromosomal Analysis of Bladder Tumors", Kansas City, Missouri, October 14, 1980.

13. 1981 Annual Meeting of the American College of Surgeons, "Chromosomal Studies of Transitional Cell Carcinoma", San Francisco, California, October 11‑16, 1981.

14. Annual Meeting of South Central Section of the American Urological Association, "Urinary Candidiasis ‑ An Update", Dallas, Texas, September 10‑13, 1981.

15. Panel Member, Annual Meeting of South Central Section of the American Urological Association, "Management of Urinary Tract Infection", Dallas, Texas, September 10‑13, 1981.

16. 77th Annual Meeting of American Urological Association, "Cytogenetic Aberrations in Bladder Carcinoma", Kansas City, Kansas, May 16‑20, 1982.

17. 1982 Annual Meeting of South Central Section of the American Urological Association, "Chromosomes: Potential Markers for Bladder Cancer", New Orleans, Louisiana, September 12‑15, 1982.

18. 1981 Annual Meeting of South Central Section of the American Urological Association, "The Fallibility of the Griess (Nitrite) Test", New Orleans, Louisiana, September 12‑15, 1982.

19. Member of Panel at the 1981 Annual Meeting of South Central Section of the American Urological Association, "Management of Urinary Tract Infection", New Orleans, Louisiana, September 12‑15, 1982.

20. 61st Annual Meeting of the South Central Section of the American Urological Association, "A New and Rapid Method for Detection of Pyuria by Leukocyte Esterase Reaction", New Orleans, Louisiana, September 12‑15, 1982.

21. 62nd Annual Meeting of the South Central Section of the American Urological Association, "Reassessment of the Erectile Dysfunction", St. Louis, Missouri, November 7, 1983.

22. 62nd Annual Meeting of the South Central Section of the American Urological Association, "Mezlocillin A Meg Spectrum Penicillin in the Treatment of Urinary Tract Infection", St. Louis Missouri, November 8, 1983.

23. Annual Spring Symposium in O/GYN on Conception and Contraception: An Active Approach, "Modern Male Contraception", Oklahoma City, Oklahoma, June 8, 1984.

24. Annual Meeting of the Oklahoma State Urologic Association, "Evaluation of the Male Infertility", Oklahoma City, Oklahoma, June 15, 1984

25. Annual Meeting of the American Fertility Society, "The Histology of Rat Testis in Experimentally Induced Pyelonephritis", New Orleans, Louisiana, April 3‑7, 1984.

26. 63rd Annual Meeting of the South Central Section of the American Urological Association, "The Effect of Pyelonephritis in Rat Testis", Houston, Texas, October 4, 1984.

27. 70th Annual Clinical Congress, American College of Surgeons, "Flow Cytometric Evaluation of Altered Spermatogenesis Induced by Systemic Infection", San Francisco, California, October 22, 1984.

28. III International Congress of Andrology, "Cytogenetic Effects of TCCD (DIOXIN): A Perspective on FERTILITY", Boston, Massachusetts, April 27 ‑ May 02, 1985.

29. 80th Annual Meeting of American Urological Association, "Abnormal Glycosaminoglycan Excretion in Patients with Chronic Interstitial Cystitis", Atlanta, Georgia, May 13, 1985.

30. 80th Annual Meeting of American Urological Association, "The Study of Testicular Cell Population ~y Flow Cytometry",Johnny B. Roy, L. Gay Bernitsky, G. P. Hemstreet, III, Lawrence E. DeBault, Sam Abraham, Atlanta, Georgia, May 13, 1985

31. Annual Meeting of American Fertility Society, "Heparin Catalysis of Sperm Capacitation in vitro", Chicago, Illinois, September 27 ‑ October 02, 1985. (POSTER)

32. 64th Annual Meeting of the South Central Section of the American Urological Association, "Hemorrhagic Evaluation of the Urologic Patient and Emboli Prevention", Guadalajara, Mexico, November 12, 1985.

33. 64th Annual Meeting of the South Central Section of the American Urological Association, "Trends in Evaluation of Male Infertility", Guadalajara, Mexico, November 12, 1985.

34. 81st Annual Meeting of American Urological Association, "The Mechanism for Low Glycosaminoglycan Excretion in Interstitial Cystitis and Mechanisms for Protection of Bladder from Urine", Hurst, R.E., Parson, C.L. and Roy, J.B. New York, New York, May 18‑22, 1986.

35. 81st Annual Meeting of American Urological Association, "Heparin Catalyzes "Functionalization" of Human Sperm in Dose‑Dependent Manner in the Zona‑Free Hamster Ova Penetration Assay", New York, New York, May 18‑22, 1986.

36. 11th Annual Meeting of American Society of Andrology, "Does Contaminant Dioxin Pose Genetic and Human Reproductive Risks", Grand Rapids, Michigan, April 20‑22, 1986.

37. 65th Annual Meeting of South Central Section of the American Urological Association, "Decreased Glycosaminoglycan Urinary Excretion in Chronic Interstitial Cystitis Patients", San Antonio, Texas, October 1‑4, 1986. (Poster)

38. 65th Annual Meeting of South Central Section of The American Urological Association, "Sperm Enhancement Technique", San Antonio, Texas, October 1‑4, 1986.

39. 72nd Annual Clinical Congress, American College of Surgeons, "Decreased VIP Immunoreactivity in Cavernous Tissue from Men with Organic Erectile Failure", New Orleans, Louisiana, October 20, 1986.

40. The American Fertility Society/Canadian Fertility and Andrology Society, "Objective Assessment of Improvement in Sperm Motility after In‑Vitro Enhancement", Roy, J.B. and Enfolded, S.E., Toronto, Canada, September 27 ‑October 2, 1986. (Poster)

41. Twelfth Annual Meeting of American Society of Andrology, "Direct and Indirect Immunologic Response Following Acute Testicular Torsion", Denver, Colorado, March 6‑9, 1987. (Poster)

42. South Central Section Post‑Graduate Seminar, AUA, "Urinary Candidiasis", Houston, Texas, March 21, 1987.

43. South Central Section Post‑Graduate Seminar, AUA, "Interstitial Cystitis", Houston, Texas, March 21, 1987.

44. 82nd Annual Meeting of American Urological Association, "Distribution of Heparin‑Bindinq Sites on the Surface of sperm", Anaheim, California, May 17‑21, 1987. (Poster) J. Urol. 137(4):163, 1987.

45. 82nd Annual Meeting of American Urological Association, "Does Atrial Natriuretic Peptide (ANP) Play a Role in Tumescence" Anaheim, California, May 17‑21, 1987. J. Urol. 137(4):202, 1987.

46. 66th Annual Meeting, South Central Section of AUA in Cooperation with The British Association of Urologic Surgeons, "Immunologic Response to Acute Testicular Torsion", London, England, October 25‑28, 1987. (Poster)

47. 66th Annual Meeting, South Central Section of AUA in Cooperation with The British Association of Urologic Surgeons, "Vasoactive Intestinal Peptide (VIP) Role in Penile Tumescence', London, England, October 25‑28, 1987.

48. 83rd Annual Meeting of American Urological Association, "Clinical Trials of Intracavernous Vasoactive Intestinal Peptide to Induce Penile Erection", Boston, MA, June 3‑7, 1988.

49. 83rd Annual Meeting of American Urological Association, "Urinary Glycosaminoglycan Excretion As a Diagnostic Test for Interstitial Cystitis", Boston, MA, June 3‑7, 1988.

50. 83rd Annual Meeting of American Urological Association, "Screening for Malignancy in Interstitial Cystitis Using Quantitative Fluorescence Image Analysis", Boston, MA, June 3‑7, 1988.

51. Evaluation and Management of Infertility in the Male: Initial Speaker: University of Health Health Sciences, College of Osteopathic Medicine, Kansas City, MO. Sept. 17, 1988.

52. 67th Annual Meeting of South Central Section of the American Urological Association, "The Use of VIP in Induction of Erection", Colorado Springs, CO, October 16‑19, 1988.

53. 67th Annual Meeting of South Central Section of the American Urological Association, "Pitfalls of BCG Therapy", Colorado Springs, CO, October 16‑19, 1988.

54. 67th Annual Meeting of South Central Section of the American Urological Association, "The Efficacy of Pentosanpoly sulphate (Elmiron) in the Treatment of Interstitial Cystitis", Colorado Springs, CO, October 16‑19, 1988. (Poster)

55. 67th Annual Meeting of South Central Section of the American Urological Association, "Assay of Urinary Glycosaminoglycan (GAG) Levels as a Marker for the Diagnosis of Interstitial Cystitis", Colorado Springs, CO, October 16‑19, 1988. (Poster)

56. Increased Urinary Glycosaminoglycan Excretion after Bladder Distension in Interstitial Cystitis Patients. Hurst, R.E., Roy, J.B., and Young, J.L., J. Urol., 141:A, 1989.

57. Interstitial Cystitis and Carcinoma in‑situ Differentiation Using Quantitative Fluorescence Image Analysis. Hurst, R.E. Roy, J.B., and Hemstreet, G.P., J. Urol., 141:A, 1989.

58. Further Modification of the Transvaginal Repair for Stress Incontinence. 68th Annual Meeting of South Central Section of the American Urological Association. Orlando, Fl. Nov. 15‑18, 1989

59. 68th Annual Meeting of South Central Section of the American Urological Association, "Effects of Freezing on Semen Quality". Orlando, Fl. Nov. 15‑18, 1989.

60. 68th Annual Meeting of South Central Section of the American Urological Association. "Endoscopic Balloon Dilatation of the Prostate". Orlando, Fl. Nov. 15‑18, 1989.

61 "Treatment of Benign Prostatic Hyperplasia (BAH) with Proscar, A 5 Reductase Inhibitor. (Member of Proscar Study Group). Workshop Conference on Androgen Therapy, Marco Island, Fl. Jan. 18, 1990.

62. IV World Meeting on Impotence "A Clinical Trial of Intracorporal Injection of Papaverine/Phentolamine vs. PGE, vs Topical Nitroglycerine Ointment in the Treatment of Erectile Dysfunction" Rio de Janeiro, Brazil. Sept. 2‑6, 1990.

63. Medical Management of BPH. Invited Speaker: Texas Tech. Academic Health Center. El Paso, TX. April 20, 1990.

64. Urinary glycosaminoglycan Excretion with Interstitial Cystitis Urologic Controls and Normals. Robert E. Hurst, Johnny B. Roy, James Young, C. Lowell Parson. J. Urol 143:278A, 1990.

65. Sexual Dysfunction at 40 - Something. Invited Speaker: Texas Tech. Academic Health Center. El Paso, TX. April 20, 1990.

66. 69th Annual Meeting of the South Central Section of the American Urological Association "Interstitial Cystitis: The Leaky Epithelium Concept" Santa Fe, N.M. October 14‑16, 1990

67. Bladder Volume as a Prognostic Index for Response to Elmiron Therapy in Interstitial Cystitis. Johnny B. Roy, James Young, Robert Hurst, and Li'l Parsons. J. Urol 145:411A, 1991 .

68. 70th Annual Meeting of the South Central Section of the American Urological Association "Transcystopic Balloon Dilatation of the Prostate". Maui, HI, November 19, 1991.

69. 70th Annual Meeting of the South Central Section of the American Urological Association "Vacuum Devices for Impotence Therapy". Maui, HI, November 1991.

70. 70th Annual Meeting of the South Central Section of the American Urological Association. "Clinical Trials of Intracorporal Injection of Papaverine/Phentolamine vs. PGF vs. Topical Nitroglycerine Ointment with Treatment of Impotence". Maui, HI, November 20, 1991.

71. 17th Annual Meeting of the American Society of Andrology. "Effects of spinal cord transection and MK‑801 on CGRP immunoreactive fibers in the rat penis". Harris, C.H., J.B. Roy, J. Holzbeierlein, R.E. Papka and D.L.McNeill. Bethesda, Maryland, March 27‑30, 1992.

72. 6th Annual Meeting of The Society for Basic Urologic Research. "Prostatic responses to neurohypophyseal hormones." S.I. Said, H. Sharaf, J.B. Roy, M. Bodansky. Washington, D.C. May 9, 1992

73. 6th Annual Meeting of The Society for Basic Urologic Research. "Isolation of characterization of (defence) proteoglycan from bladder surface". R.E. Hurst, R. Zebrowski, J.B. Roy. Washington, D.C. May 9, 1992

74. 87th Annual Meeting of the American Urological Association. "Quantitative comparison of cytoskeletal actin in normal sperm and asthenospermia." Johnny B. Roy, David Fang, JianYu Rao, Abhay Vaidya. Washington, D.C. May 10‑14, 1992

75. 87th Annual Meeting of the American Urological Association. Long term results of balloon dilatation of the prostate." Johnny B. Roy, Tarek A. Ibrahim, William L. Parry. Washington, D.C. May 10‑14, 1992.

76. Advances in the Management of BPH. Guest Speaker: Mississippi Urological Society. October 9-11, 19992. Jackson, Mississippi.

77. "Long Term Results of Balloon Dilatation of the Prostate" Presented at the 1992 Annual Mtg. of the Northeastern and the New England Sections of the AUA. Sept. 13‑16, 1992, Toronto,Canada

78. Interstitial Cystitis: Oklahoma State Medical Society Mtg., Tulsa, OK, Aprilo 24, 1993.

79.. "Distribution of Nitric Oxide Synthase-Positive Nerve Fiber in the Corpus Cavernosum for Impotent Men" J. Urol 149:284A, 1993.

80. Vasoactive Intestinal Peptide (VIP) and Nitric Oxide (NO) as Co-Transmitters of the Relaxation of Human Penile Cavernous Tissue. Presented at the Society for Basic Urologic research in San Antonio, TX, May 13, 1993.

81.. "Etiology and Management of Interstitial Cystitis". Moderator and discussant: Interstitial Cystitis Symposium. HCA/Presbyterian Hospital, Oklahoma City, OK. August 21, 1993

82. Discussant on "Androgen Dependence of Nitric Oxide". 49th Annual Mtg. of the American Fertility Society. Orlando, FL. October 12-13, 1993.

83. "Advances in the Management of BPH". 14th Annual Southwest Medical Congress. El Paso, TX. November 5, 1993.

84 "Urodynamic Evaluation". Conference on Urinary Incontinence. Oklahoma Geriatric Education Center. Oklahoma City, OK. January 28, 1994.

85. Advances in the Management of BPH. Invited Speaker: Austin Society of Internal Medicine. March 2, 1994. Austin, TX.

86. "Deficit of Chondroitin Sulphate Proteoglycans on the Bladder Surface in Interstitial Cystitis". Hurst, R.E., Roy, J. B., et. al. J. Urol. 151:285A. 1994.

87. "PSA-Its Role and Idiosyncrasies in the Management of Prostate Disease". J. H. Dunn Symposium. Baptist Health Center. Oklahoma City, OK. January 15, 1994

88. "Nitric Oxide and Tumescence". 73rd Annual Mtg. of the South Central Section of the AUA. Vancouver, B. C. August 27-31, 1994.

89. "Comparative Pharmacokinetics and Hemodynamics of the Topical Application to the Penis of Nitroglycerin Ointment vs. An Aqueous Nitroglycerin Gel in Health Male Volunteers". Presented at the 6th World Meeting on IMpotence. Singapore, Sept. 12-16, 1994.

90. "Prostate Cancer". 14th Annual Family Practice Program. University of Kansas Medical School, Wichita, KS. December 2, 1994.

91. "The Aging Prostate" presented at the Annual Meeting of the National Kidney Foundation of New Mexico. Santa Fe, NM. March 24, 1995

92. "Urodynamic Findings in Patients with Interstitial Cystitis". Petrone, R. L., Agha, A. H., Roy, J. B., Hurst, R. E. J Urol 153:290A. 1995.

93. "The Ideal Way To Measure the Height of the Prostate for Transrectal Ultrasonographic Volumetry". Agha, A.H., Roy, J. B., and Culkin, D. J. J Urol. 153:301A. 1995.

94. "The Effects of Finasteride on Serum PSA in Men with BPH". Waldstreicher, J., Tocker, P., Change, J., Roy, J. B. , et. al.: J Urol 153:396A. 1995.

95. "The Effect of Chronic Cocaine Consumption on Androgen Binding Sites and Androgen Receptor Expression". Chung, K. W., Nguyen, B., Om, A. S., Roy, J. B. J Urol 153:398A. 1995

96. Prostate Specific Antigen Is Metabolized in the Liver. Agha, A., Schechter, E., Roy J.B., Culkin, D.J. 91st Annual Mtg., American Urological Association. May 4-9, 1996. Orlando, Fl.

97. Abnormal G-actin Levels in Voided Urine Cells from Interstitial Cystitis Patients. Hurst, R., Roy, J.B. et al. 91st Annual Mtg., American Urological Association. May 4-9, 1996. Orlando, Fl.

98. A Double-blind, Placebo-controlled Trial of the Hemodynamic Effects of Topical Application to the Penis of an Aqueous Nitroglycerin Gel in Health Male Volunteers. Roy, J.B., Petrone, R. L., and Agh,a A.H. J Urol 155:595A. 1996.

99. Restoration of Erectile Function by Transurethral Alprostadil Improves Quality of Life for Patients and Partners. Fishman I, Adelglass JEH, Roy, J, et.al: presented at South Central Section of the AUA, Vail CO. Sept. 7-11, 1996.

100. Comparative Pharmacokinetics and Hemodynamics of the Topical Application to the Penis of Nitroglycerin Ointment vs an Aqueous Nitroglycerin Gel in Health Males”. Roy JB, Petrone RL, Agha, AH: presented at South Central Section of the AUA, Vail CO. Sept. 7-11, 1996.

101. Dose Response Efficacy and Safety of Topical Application to the Penis of Aqueous Nitroglycerin Cream in Men with Erectile Dysfunction. Roy, J.B., Petrone, R.L.: presented at VII World Meeting on Impotence San Francisco, CA Nov. 3-7, 1996

102. The Durability of Response and Satisfaction with Vacuum Device for Erectile Dysfunction. Agha, A.H., Roy, J.B.,Culkin, D.J. J. Urol. 157(4):146, 1997.

103. Transurethral Alprostadil for the Treatment of Erectile Dysfunction: Long-Term Safety

Profile. Roy, J.B., Goldburg, K.A., Adelglass, J.M., Fishman, I.J.,75^th Annual Meeting

of South Central Section of AUA. Bermuda, November 8-12, 1997.

104. The Effect of Finasteride on the Natural Progression of Increasing Prostate Volume Over

Time. Bonilla, J.,Hudson, P.B….Roy, J.B. Presented at European Association of Urology

Congress, Barcelona, Spain, March 24, 1998.

105. Long-term Experience with Finasteride in Treatment of B.P.H.: Sexual Adverse

Experiences are Similar Between Treated and Placebo Groups After the First Year of

Therapy. Roy, J.B., et al, Presented at 93^rd Annual Mtg. Amer. Urol. Assoc., San Diego,

CA, June 3, 1998.

106. Observation on the Natural History of B.P.H. in Men Followed in a Four-Year Placebo-

Controlled Trial. Holtgrewe, L. et al for the PLESS Study Group (Roy, J.B.: Member of

the Group) Presented at 93^rd Annual Mtg. Amer. Urol. Assoc. San Diego, Ca. June 3^rd,

1998.

107. Baseline Symptom Severity and Its Relationship to Long-Term Response to Finasteride.

Kaplan,S. et al for the PLESS Study Group. Presented at 93^rd Annual Mtg. Amer. Urol.

Assoc. San Diego, Ca June 3^rd, 1998.

XII SUPERVISED RESEARCH

1985 Michael Crawford, M.D. "Hamster Egg Penetration Assay".

1985 James Mays, M.D. "Experimental Unilateral Torsion Of Testis And The Resultant Immune Response".

1988 David X. Vu (Premed. student at Dartmouth) "Study of sperm motility".

1989 Kelly Means, MS II, American Foundation For Urologic Diseases (AFUD) Summer Fellowship "Semen Cryopreservation".

1990 Khan P. Tran, MS II, American Foundation For Urologic Diseases (AFUD) Summer Fellowship‑"Role Of Bladder Surface Macromolecules In Maintaining Bladder Defense".

1991 David Fang (Undergraduate Premed. student‑John Hopkins University), Department of Urology Research Fund "Quantitative Comparison Of Cystoskeleton In Normal And Asthenospermics".

1991 Tarek Ibrahim, M.D. Fellowship in Impotency. Sponsored by the Educational Ministery of Egypt

1991 Clifford Harris, MS IV, American Foundation For Urologic Diseases (AFUD) "Enhancing Viscero‑visceral Reflexes With MK‑801 on CGRP Immunoreactive Sensory Fibers In Rats With Spinal Cord Transection".

1992 Atul Vaidya (Premed. student at Brown) Merck Summer Scholarship Fund "Origin and distribution of diaphroase positive neurons and fibers innervating the urinary bladder of the rat".

93-95 Arif H. Agha, M.D., F.R.C.S. Fellowship in Neurourology and Impotence.

1993 Brian Nyugen (Premed. student at O.S.U.) "Effects of cocaine injection in rats on androgen receptors in the prostate and genitals".

1993 Atul Vaidya (Premed. student at Brown). "Studies on innervation of the rat bladder and the ascending inputs to supraspinal centers involved in micturation".

XIII. Innumerable invited lectureships, session moderations, panel discussions -- regionally, nationally and internationally.